ResearchACIU
ACIU: FY25 Deep Dive
Published 1 min read
Summary
AC Immune FY25 at CHF 4M. NI CHF -67M; EPS CHF -0.67.
FY25 revenue CHF 4M; OI CHF -69M; NI CHF -67M; EPS CHF -0.67.
AC Immune FY25 (Dec 31, 2025 (currency: CHF)) at CHF 4M revenue. OpInc CHF -69M; NI CHF -67M; EPS CHF -0.67. Biotech — CHF reporting.
